Washington (Sinclair Broadcast Group) — At least two coronavirus vaccine candidates may be granted an emergency license by late November, according to people involved in Operation...
Johnson & Johnsonof JNJ 0.61% The Covid-19 vaccine elicited an immune response in most people who received injections in a small initial trial and showed...
Key Point Johnson & Johnson report successful trial of its candidate COVID-19 vaccine, Ad26.COV2.S, in hamsters July also revealed successful testing of vaccines in non-human primates...
Katie Adams – Tuesday, July 07 2020
Governments and pharmaceutical companies are considering ways to deploy coronavirus vaccines, including booking the first batch with healthcare workers. At least eight of the more than...
Recent Comments